Histone deacetylase 1 expression in gastric cancer

Oncology Reports

Volumn 26, Issue 4, 2011, Pages 777-782

  Sudo, Tomoya ^a,b   Mimori, Koshi ^a   Nishida, Naohiro ^a   Kogo, Ryunosuke ^a   Iwaya, Takeshi ^a   Tanaka, Fumiaki ^a   Shibata, Kohei ^a   Fujita, Hiromasa ^b   Shirouzu, Kazuo ^b   Mori, Masaki ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Differential display; Gastric cancer; Histone deacetylase 1; Prognostic factor

Indexed keywords

COMPLEMENTARY DNA; HISTONE DEACETYLASE 1; MESSENGER RNA;

AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DISEASE ASSOCIATION; FEMALE; GENE IDENTIFICATION; GENE ISOLATION; GENE OVEREXPRESSION; GENETIC MARKER; HISTONE DEACETYLASE 1 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NORTHERN BLOTTING; ONCOGENE; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

AGED; FEMALE; HISTONE DEACETYLASE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79960790220     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1361     Document Type: Article

References (27)

1. Mori M, Staniunas RJ, Barnard GF, Jessup JM, Steele GD Jr and Chen LB: The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 105: 820-826, 1993. (Pubitemid 23249492)
2. Mori M, Barnard GF, Staniunas RJ, Jessup JM, Steele GD Jr and Chen LB: Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 8: 2821-2826, 1993. (Pubitemid 23279111)
3. Begum NA, Mori M, Matsumata T, Takenaka K, Sugimachi K and Barnard GF: Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma. Hepatology 22: 1447-1455, 1995.
4. Liu CA, Wang MJ, Chi CW, Wu CW and Chen JY: Overexpression of rho effector rhotekin confers increased survival in gastric adenocarcinoma. J Biomed Sci 11: 661-670, 2004.
5. Wang J and Chen S: Screening and identification of gastric adenocarcinoma metastasis-related genes using cDNA microarray coupled to FDD-PCR. J Cancer Res Clin Oncol 128: 547-553, 2002. (Pubitemid 35244930)
6. Egger G, Liang G, Aparicio A and Jones PA: Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463, 2004. (Pubitemid 38715140)
7. Kawai H, Li H, Avraham S, Jiang S and Avraham HK: Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int J Cancer 107: 353-358, 2003. (Pubitemid 37266453)
8. Yoshida N, Omoto Y, Inoue A, et al: Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes. Cancer Sci 95: 496-502, 2004. (Pubitemid 38842407)
9. Schrump DS: Genomic surgery for lung cancer. J Surg Res 117: 107-113, 2004.
10. Donadelli M, Costanzo C, Faggioli L, et al: Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog 38: 59-69, 2003. (Pubitemid 37255141)
11. Kuefer R, Hofer MD, Altug V, et al: Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. Br J Cancer 90: 535-541, 2004. (Pubitemid 38258278)
12. Choi JH, Kwon HJ, Yoon BI, et al: Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn J Cancer Res 92: 1300-1304, 2001. (Pubitemid 34036893)
13. Ito T, Kito K, Adati N, Mitsui Y, Hagiwara H and Sakaki Y: Fluorescent differential display: arbitrarily primed RT-PCR fingerprinting on an automated DNA sequencer. FEBS Lett 351: 231-236, 1994. (Pubitemid 24277275)
14. Mori M, Mimori K, Shiraishi T, et al: p27 expression and gastric carcinoma. Nat Med 3: 593, 1997.
15. Mori M, Mimori K, Inoue H, et al: Detection of cancer micrometastases in lymph nodes by reverse transcriptasepolymerase chain reaction. Cancer Res 55: 3417-3420, 1995.
16. Mori M, Mimori K, Ueo H, et al: Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 68: 739-743, 1996. (Pubitemid 27062033)
17. Vigushin DM and Coombes RC: Targeted histone deacetylase inhibition for cancer therapy. Curr Cancer Drug Targets 4: 205-218, 2004. (Pubitemid 38332557)
18. Halkidou K, Gaughan L, Cook S, Leung HY, Neal DE and Robson CN: Up-regulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate 59: 177-189, 2004. (Pubitemid 38481229)
19. Ono S, Oue N, Kuniyasu H, et al: Acetylated histone H4 is reduced in human gastric adenomas and carcinomas. J Exp Clin Cancer Res 21: 377-382, 2002.
20. Kim MS, Kwon HJ, Lee YM, et al: Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7: 437-443, 2001. (Pubitemid 32298546)
21. Shim JS, Kim DH and Kwon HJ: Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. Oncogene 23: 1704-1711, 2004. (Pubitemid 38445162)
22. Scott GK, Mattie MD, Berger CE, Benz SC and Benz CC: Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 66: 1277-1281, 2006. (Pubitemid 43259904)
23. Kim SH, Ahn S, Han JW, et al: Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials. Biochem Biophys Res Commun 315: 964-970, 2004. (Pubitemid 38249397)
24. Prystowsky MB, Adomako A, Smith RV, et al: The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. J Pathol 218: 467-477, 2009.
25. Noh JH, Song JH, Eun JW, et al: Systemic cell-cycle suppression by Apicidin, a histone deacetylase inhibitor, in MDA-MB-435 cells. Int J Mol Med 24: 205-226, 2009.
26. Kang MR, Kang JS, Han SB, et al: A novel delta-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells. Biochem Pharmacol 78: 486-494, 2009.
27. Botrugno OA, Santoro F and Minucci S: Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer. Cancer Lett 280: 134-144, 2009.